[1]苏剑飞,牟睿宇,刘筱迪,等.贾英杰教授从“脾”论治前列腺癌[J].陕西中医,2023,(5):636-639.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.023]
　SU Jianfei,MOU Ruiyu,LIU Xiaodi,et al.Professor JIA Yingjie's thoughts on treating prostate cancer from the perspective of “spleen”[J].,2023,(5):636-639.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.023]
点击复制

贾英杰教授从“脾”论治前列腺癌
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年5期
页码:
636-639
栏目:
名中医经验
出版日期:
2023-05-05

文章信息/Info

Title:
Professor JIA Yingjie's thoughts on treating prostate cancer from the perspective of “spleen”
作者:
苏剑飞; 牟睿宇; 刘筱迪; 张静娴; 黄敏娜
(天津中医药大学第一附属医院 国家中医针灸临床医学研究中心,天津 300381)
Author(s):
SU Jianfei; MOU Ruiyu; LIU Xiaodi; ZHANG Jingxian; HUANG Minna
(First Teaching Hospital of Tianjin University of Traditional Chinese Tianjing 300381,China)
关键词:
前列腺癌;  脾;  黜浊培本;  贾英杰;  健脾法;  恶性肿瘤
Keywords:
Prostate cancer;  Spleen;  Chuzhuo Peiben;  JIA Yingjie;  Spleen-strengthening;  Tumors
分类号:
R 737.25
DOI:
DOI:10.3969/j.issn.1000-7369.2023.05.023
文献标志码:
A
摘要:
当前我国前列腺癌癌症负担日益加重,既往基础研究及临床实践表明中医药在前列腺癌管理方面具有重要地位。全国名中医贾英杰教授结合多年临床经验总结出“黜浊培本”的恶性肿瘤防治理论,并将其验之于前列腺癌提出“补肾不如补脾,健脾即是补肾”的重要观点。现旨在以“黜浊培本”理论为依据,从前列腺的形态生理功能、前列腺癌的证治规律、健脾法的基础与临床实践三方面,阐述贾英杰教授从“脾”论治前列腺癌的学术思想,以期为中医药治疗前列腺癌带来新的思考。
Abstract:
At present,the burden of prostate cancer in my country is increasing day by day.Previous basic research and clinical practice have shown that traditional Chinese medicine plays an important role in the management of prostate cancer.Professor JIA Yingjie,a national famous Chinese medicine practitioner,summed up the malignant tumor prevention and treatment theory of “Chuzhuo Peiben” based on years of clinical experience,and used it in the treatment of prostate cancer to put forward the important point of “Jianpi ji shi bushen,bushen bu ru bupi”.The purpose of this paper is to explore the morphological and physiological functions of the prostate,the laws of the syndrome and treatment of prostate cancer,the basis and clinical practice of the spleen-strengthening method,based on the theory of “Chuzhuo Peiben”,to explore the construction of prostate cancer from the “spleen”.On the theory of treatment,in order to bring new thinking for the treatment of prostate cancer with traditional Chinese medicine.

参考文献/References:

[1] Zheng R,Zhang S,Zeng H,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2(1):1-9.
[2] 周 琦,孙慧娟,陈 宁.中医药治疗前列腺癌的作用机制研究进展[J].中国实验方剂学杂志,2021,27(13):207-214.
[3] 王 伟,石 兵,王丽平.固肾祛湿化浊汤联合阿比特龙治疗去势抵抗性前列腺癌临床研究[J].陕西中医,2021,42(2):200-203.
[4] 秦云峰.对中医“男胞”——前列腺生理功能再认识[J].中华男科学,2003,9(1):76-78.
[5] 张耀圣,李彩芬.论男子胞[J].中医杂志,2016,57(24):2155-2158.
[6] 徐洪胜,李海松,王世桢,等.李海松教授从瘀、虚论治慢性前列腺炎经验[J].陕西中医,2022,43(10):1445-1448.
[7] 宋 健,曾进浩,刘友章,等.国医大师邓铁涛从脾论治重症肌无力临床经验[J].陕西中医,2022,43(12):1774-1777.
[8] 祁 冰,侯丽辉,吴效科.浅析“天癸”的生理[J].时珍国医国药,2008,19(5):1234-1235.
[9] 王小玉,韩凤娟.基于“天癸-肾阳-命门”学说探究卵巢癌发病机制[J].陕西中医,2021,42(9):1261-1263.
[10] 孔杏梅.“一源三歧”探源[J].中国针灸,2006,26(6):459.
[11] 姜依晴,赵志恒,周 震.“一源三歧”之男子“一源”辨析[J].中医学报,2021,36(12):2554-2557.
[12] 司 磊.男性“一源三歧”的“一源”之我见[J].河南中医,1990,10(1):50.
[13] 王晓群,李玉婷,赵林林,等.贾英杰“黜浊培本”治疗恶性肿瘤学术探讨[J].中医杂志,2021,62(7):568-571.
[14] 陈倩倩,孔凡铭,赵辰辰,等.贾英杰教授“黜浊培本”理论治疗恶性肿瘤探讨[J].天津中医药,2020,37(3):282-286.
[15] 后森林,王 颖,张建华,等.精准医学模式下放射治疗在前列腺癌中的应用进展[J].河南大学学报:医学版,2021,40(5):383-390.
[16] 石文君,贾英杰.贾英杰治疗放射性肠炎经验[J].湖南中医杂志,2019,35(1):23-24.
[17] 郭程程,焦华琛,李运伦.李东垣阴火本质探究[J].中华中医药杂志,2021,36(7):3874-3876.
[18] 邓 姣,何仲明,刘飞能,等.多西他赛治疗前列腺癌的研究进展[J].现代肿瘤医学,2021,29(21):3855-3858.
[19] 王晓群,王 潇,赵林林,等.伤寒太阴阳明思维在恶性肿瘤化疗后的运用[J].天津中医药,2018,35(10):744-745.
[20] 贾英杰,陈 军,李小江,等.前列腺癌中医证候研究的文献分析[J].辽宁中医杂志,2014,41(9):1850-1852.
[21] 徐竞一.前列腺癌患者中医体质分布特点与其危险因素的相关性分析[D].天津:天津中医药大学,2021.
[22] 郭锦芳.前列腺癌中医证型与中医体质分布规律研究[D].广州:广州中医药大学,2019.
[23] 牛潇菲,邬明歆,牟睿宇,等.贾英杰“黜浊培本”论治前列腺癌经验[J].陕西中医,2022,43(1):111-113.
[24] 牟睿宇,李小江,贾英杰.贾英杰治疗晚期前列腺癌经验[J].中医杂志,2020,61(15):1314-1317.
[25] 张菁菁,蔡心银,张紫佳,等.中药的雄激素样作用研究进展[J].现代中药研究与实践,2019,33(3):77-80.
[26] 邓仁芬,姚 杨,李小江,等.贾英杰“守方微调”治疗前列腺癌经验[J].中医杂志,2019,60(20):1724-1727.
[27] 张 瑶,李小江,贾英杰.中医“健脾利湿化瘀法”在前列腺癌治疗中的运用[J].天津中医药,2021,38(3):317-321.
[28] 孙彬栩,李小江,蔡启亮,等.“健脾利湿化瘀方”联合治疗势抵抗性前列腺癌的临床研究[J].天津中医药,2020,37(8):885-891.
[29] 李小江,冯梦晗,牟睿宇,等.“健脾利湿化瘀法”治疗中晚期前列腺癌内分泌治疗后部分雄激素缺乏综合征的临床观察[J].中草药,2020,51(21):5559-5565.
[30] 牟睿宇,贾英杰,孙彬栩,等.健脾利湿化瘀方对人前列腺癌C4-2细胞雄激素非依赖性生长的影响[J].中医杂志,2019,60(11):964-968.
[31] 李家合.基于网络药理学探讨“健脾利湿化瘀方”治疗前列腺癌的分子机理[D].天津:天津中医药大学,2020.

相似文献/References:

[1]史建华,刘瑞强,尹茂轩,等.生地黄制剂对前列腺癌晚期患者血清标志物的改善作用与安全性研究*[J].陕西中医,2019,(8):1073.
　SHI Jianhua,LIU Ruiqiang,YIN Maoxuan,et al.Effect and safety of Shengdihuang decoction on serum markers of patients with advanced prostate cancer[J].,2019,(5):1073.
[2]张召杨,孙增涛 △,刘南飞,等.肺脾相关理论及临床应用研究*[J].陕西中医,2020,(11):1623.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.028]
　ZHANG Zhaoyang,SUN Zengtao,LIU Nanfei,et al.Theory and clinical application of lung and spleen[J].,2020,(5):1623.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.028]
[3]朱梓波,吴梦丽,刘振雄,等.禤国维“温通”法治疗系统性硬皮病经验[J].陕西中医,2021,(11):1598.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.024]
　ZHU Zibo,WU Mengli,LIU Zhenxiong,et al.XUAN Guowei's experience in treating systemic scleroderma with “Wentong” method[J].,2021,(5):1598.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.024]
[4]沈毅韵,朱一冰,张艳涛,等.肺脾肾湿论治小儿过敏性鼻炎作用机制研究进展[J].陕西中医,2023,(1):133.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.033]
　SHEN Yiyun,ZHU Yibing,ZHANG Yantao,et al.Research progress on the mechanism of treating allergic rhinitis in children with the theory of lung,spleen and kidney dampness[J].,2023,(5):133.[doi:DOI:10.3969/j.issn.1000-7369.2023.01.033]
[5]苏坤涵,刘万里.从“善治脾者,能调五脏”论治功能性消化不良[J].陕西中医,2023,(2):216.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.018]
　SU Kunhan,LIU Wanli.Explore the treatment of functional dyspepsia from “Those who are good at curing the spleen can regulate the five internal organs”[J].,2023,(5):216.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.018]
[6]周颖丽,罗 茜,尹紫薇,等.郭志华治疗高脂血症临床经验[J].陕西中医,2023,(6):781.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.023]
　ZHOU Yingli,LUO Xi,YIN Ziwei,et al.Guo Zhihua's clinical experience in the treatment of hyperlipidemia[J].,2023,(5):781.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.023]
[7]刘博文,李晓斌,马贵萍,等.名中医胡世平运用“培养、招纳、解散”三法治疗慢性肝病腹水经验[J].陕西中医,2024,(6):812.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.019]
　LIU Bowen,LI Xiaobin,MA Guiping,et al.Experience of Hu Shiping in treating ascites in chronic liver disease with the three methods of “cultivation,recruitment and dissolution”[J].,2024,(5):812.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.019]

备注/Memo

备注/Memo:
基金项目:天津市自然科学基金资助项目(19JCZDJC37000)
更新日期/Last Update: 2023-05-09